Amgen AMGN
NASDAQ AMGN
$460.42 +0.14 (+0.03%)
At close: Nov 6, 2026 · 4:00 PM EST

Amgen (AMGN) Asset Writedowns and Impairment (2022 - 2026)

Updated

Amgen's Asset Writedowns and Impairment came in at $1.2 billion for FY2025, up 654.7% from $159 million in FY2024.

Analysis

Amgen (AMGN) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

Going back to FY2009, Amgen's Asset Writedowns and Impairment data covers 10 years.

  • Asset Writedowns and Impairment carries a three-year compound annual growth rate of 28.4% (FY2022 to FY2025).
  • The FY2025 figure represents the highest annual Asset Writedowns and Impairment in data going back to FY2009.
  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $159 million in FY2024 (-81.3%), $851 million in FY2023 (+50.1%) and $567 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 63.00 Mn
Sep 30, 2025 400.00 Mn
Mar 31, 2025 800.00 Mn
Dec 31, 2024 30.00 Mn
Sep 30, 2024 61.00 Mn
Mar 31, 2024 68.00 Mn
Dec 31, 2023 851.00 Mn
Dec 31, 2022 2.00 Mn
Sep 30, 2022 5.00 Mn
API Access

Amgen Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AMGN&period=max&api_key=YOUR_API_KEY